-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Bone Biologics Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2021.
- Bone Biologics Corp Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $33.1K.
- Bone Biologics Corp annual Income Tax Expense (Benefit) for 2021 was $1.6K, unchanged from 2020.
- Bone Biologics Corp annual Income Tax Expense (Benefit) for 2020 was $1.6K, a 0.19% decline from 2019.
- Bone Biologics Corp annual Income Tax Expense (Benefit) for 2019 was $1.6K, a 7.29% decline from 2018.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)